A director at Medpace Holdings Inc sold 39,342 shares at 404.764USD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years c...
Terns Pharmaceuticals to Participate in UBS Obesity Therapeutics Day FOSTER CITY, Calif., May 17, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small molecule product candidates to address serious diseases, including oncology and obesity, today announced that members of senior management will be participating in a virtual fireside chat at UBS Obesity Therapeutics Day on Thursday, May 23, 2024 at 1:00 p.m. ET. A live webcast of the fireside chat will be available on...
Five Directors at Evolus Inc sold after exercising options/sold 60,276 shares at between 12.645USD and 12.929USD. The significance rating of the trade was 54/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the com...
Terns Pharmaceuticals Reports First Quarter 2024 Financial Results and Corporate Updates Interim data from initial dose escalation cohorts from Phase 1 CARDINAL trial of TERN-701 (allosteric BCR-ABL) in CML expected in 2H24 Top-line data from Phase 1 trial of TERN-601 (oral GLP-1) for obesity expected in 2H24 Cash, cash equivalents and marketable securities of $241 million, expected to provide runway into 2026 FOSTER CITY, Calif., May 13, 2024 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical stage biopharmaceutical company developing...
NVIDIA Grace Hopper Ignites New Era of AI Supercomputing From Climate and Weather to Scientific Exploration, Switzerland’s Alps Supercomputer, France’s EXA1-HE Supercomputer and Others to Deliver 200 Exaflops of AI for Groundbreaking Research Using Energy-Efficient Grace-Based Systems HAMBURG, Germany, May 12, 2024 (GLOBE NEWSWIRE) -- ISC—Driving a fundamental shift in the high-performance computing industry toward AI-powered systems, NVIDIA today announced nine new supercomputers worldwide are using to speed scientific research and discovery. Combined, the systems deliver 200 exaflops...
NVIDIA Accelerates Quantum Computing Centers Worldwide With CUDA-Q Platform Supercomputers in Germany, Japan and Poland Incorporate Grace-Hopper and Quantum-Classical Accelerated Supercomputing Platform to Advance Quantum Computing Research HAMBURG, Germany, May 12, 2024 (GLOBE NEWSWIRE) -- ISC -- NVIDIA today announced that it will accelerate quantum computing efforts at national supercomputing centers around the world with the open-source . Supercomputing sites in Germany, Japan and Poland will use the platform to power the (QPUs) inside their NVIDIA-accelerated high-performance...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.